[Substance]

id :: 38
name :: 5-MeO-MIPT
url :: https://www.erowid.org/chemicals/5meo_mipt/5meo_mipt.shtml
category :: Chemicals
commonNames :: Moxy
effectsClassification :: Psychedelic Tryptamine
chemicalName :: N-isopropyl-5-methoxy-N-methyl-tryptamine;   N-[2-(5-methoxy-1 H-indol-3-y)ethyl]-N-methylpropan-2-amine
description :: 5-MeO-MIPT is a stimulating psychedelic tryptamine sometimes compared to 5-MeO-DIPT (Foxy). It is uncommon and has little history of human use.
imageURL :: https://www.erowid.org/chemicals/5meo_mipt/images/5meo_mipt_summary1.jpg
basicsURL :: https://www.erowid.org/chemicals/5meo_mipt/5meo_mipt_basics.shtml
effectsURL :: https://www.erowid.org/chemicals/5meo_mipt/5meo_mipt_effects.shtml
imagesURL :: https://www.erowid.org/chemicals/5meo_mipt/5meo_mipt_images.shtml
lawURL :: https://www.erowid.org/chemicals/5meo_mipt/5meo_mipt_law.shtml
doseURL :: https://www.erowid.org/chemicals/5meo_mipt/5meo_mipt_dose.shtml
chemistryURL :: https://www.erowid.org/chemicals/5meo_mipt/5meo_mipt_chemistry.shtml
researchChemicalsURL :: https://www.erowid.org/psychoactives/research_chems/research_chems.shtml

[Basics]
description :: 5-MeO-MIPT is one of the less common psychedelic tryptamines that was developed by Alexander Shulgin in the 1980s. It shares some similarities with 5-MeO-DIPT (Foxy Methoxy). One of the isopropyl groups of 5-MeO-MIPT is simply exchanged by a one carbon (methyl) chain resulting in the most active asymmetrically N-methyl N-isopropyl substitution pattern. [ Main 5-MeO-MIPT Vault ]
descriptionSections :: dose	A standard oral dose of 5-MeO-MIPT is between 2 and 7 mg.
price	In 2015, 5-MeO-MIPT is sold for between $50 - $125 USD per gram at single gram prices. Prices are higher for lower amounts. As with any recreational substance, single dose (7-10mg) prices at events are dependent on the market, but are usually in the $10-20 range.
law	5-MeO-MIPT is not specifically controlled in the United States, but could be considered an Analogue of 5-MeO-DIPT, a Schedule I drug, if it were intended for human use.
chemistry	N-isopropyl-5-methoxy-N-methyl-tryptamine (5-MeO-MiPT) is a synthetic chemical tryptamine and thus is structurally related to other tryptamines (natural and synthetic), such as 5-MeO-DMT, N,N-DMT, psiloc(yb)in and serotonin.
pharmacology	Pharmacology Summary Needed.
production	Production Summary Needed.
history	The first publication of the synthesis and pharmacology of this compound was in 1985 in Journal of Medicinal Chemistry by Repke, Grotjahn & Shulgin [article].
terminology	The Substance:5-MeO-MIPT. The Experience:Tripping.
effects :: Oral 5-MeO-MIPT has some similarities with 5-MeO-DIPT. Users have reported aphrodisiac effects, minor changes in visual perception, mental stimulation, new perspectives, feelings of insight, emotional shifts, muscle tension, and mild tremor. The body load seems to be milder than with 5-MeO-DIPT. Sometimes there is a tendency of dreamy separation of mind and body as with 5-MeO-DMT. With the smoking route, more visuals and a "rush" are reported.
effectsSections :: onset	Depending on how much and how recently the user has eaten, oral 5-MeO-MIPT generally takes 10-20 minutes to start to take effect. Smoked freebase usually comes on within seconds.
duration	Due to the small number of reports and a wide variation in reported durations for this chemical, it is difficult to give reliable estimates of length of action. Some users have reported effects completely abating within 4-6 hours, while others have reported residual stimulation and inability to sleep for several additional hours.
visuals	Visuals Summary Needed.
problems :: Some users report unpleasant body effects or "body load". Unpleasant stomach effects, gastro-intestinal distress (diarrhea, cramps & gas) are not uncommon. In some cases there are difficulties with falling asleep for some hours after having returned to baseline, but there is less stimulation and body load than with 5-MeO-DIPT. There are cases of cardiac problems (tachycardia and pain), especially after high doses (over 10 mg). Other possible negative effects are difficult experiences as possible with nearly all psychedelics. The Psychedelic Crisis FAQ addresses some of the issues involved in dealing with a difficult trip.
problemsSections :: contraindications	5-MeO-MIPT and MAOIs are a potentially dangerous combination. It is likely that MAOIs could increase the effects of 5MeO-MIPT unpredictably. Taking this chemical while on prescription MAOIs is strongly discouraged. MAOIs are most commonly found in the prescription anti-depressants Nardil (phenelzine), Parnate (tranylcypromine), Marplan (isocarboxazid), Eldepryl (l-deprenyl), and Aurorex or Manerix (moclobemide). Ayahuasca also contains MAOIs (harmine and harmaline). Check with your doctor if you are not sure whether your prescription medication is an MAOI. Do not operate heavy machinery. Do Not Drive. Individuals currently in the midst of emotional or psychological upheaval in their everyday lives should be careful about choosing to use psychedelics such as 5-MeO-MIPT as they can trigger even more difficulty. Individuals with a family history of schizophrenia or early onset mental illness should be extremely careful because psychedelics have been known to trigger latent psychological and mental problems. Combining multiple psychoactive tryptamines, such as taking 4-oxygenated tryptamines (e.g. psilocybin, 4-AcO-DIPT, 4-AcO-MIPT) with 5-oxygenated ones such as 5-MeO-MIPT or 5-MeO-DIPT, may lead to unexpected potentiation of the action of each substance. This means that low doses of each, in combination, may produce an unexpectedly strong action. Individuals with seizure or convulsive disorders or heart problems may be at higher risk for health problems when taking psychedelics. Diabetics should monitor their blood sugar closely, as there have been some reports of problems.
addiction	As with most psychedelics 5-MeO-MIPT seems to be neither physically addicting nor likely to cause psychological dependence. But As with most substances, some people will use it more frequently than they are comfortable with. There is a short period of tolerance after 5-MeO-MIPT use. Using it two days in a row is likely to lead to a diminished experience the second day, though spaced 5-7 or more days apart, this effect is nearly non-existent.
long	Long Term Health Problems Summary Needed.
death	Risk of Death Summary Needed.

[Effects]
duration :: 5-MeO-MIPT Duration
Oral
Total Duration	4 - 7 hrs
Onset	15 - 20 mins
Coming Up	15 - 20 mins
Plateau	1 - 3 hrs
Coming Down	1 - 2 hrs
&nbsp;	&nbsp;
After Effects	2 - 4 hrs
Hangover / Day After	- - -
positiveEffects :: euphoria, mood lift	increased tactile sensations	sensory enhancement (taste, smell, etc)	sexually interesting	emotional opening	relaxation	powerful "rushing" sensation (smoked)	immersive experiences (smoked)
neutralEffects :: feelings of body & muscle energy, buzzing	visual distortions	color intensification ( higher doses / smoked)	disorientation (smoked)	sometimes dissociation (smoked)	tremor (smoked)	emotional lability (smoked)
negativeEffects :: possible stomach discomfort, gas & vomiting	anxious stimulation	muscle tension / discomfort	difficulty sleeping for 4-8 hours after peak in some people
description :: The effects of 5-MeO-MIPT (oral) have been described as somewhere between the effects of 5-MeO-DIPT (Foxy) and 5-MeO-DMT, without being a combination of the two. Reported effects vary dramatically from sleepy to speedy and from sense enhancing to mind-numbing.	
Users describe a speedy body load, predominantly at the beginning of the experiment and a kind of 5-MeO-DMT like dissociation rather at the end. The turned on body load in some people enhances erotic qualities as with 2-CB or 5-MeO-DIPT (Foxy). Some visual effects are reported, especially at higher doses (10 mg and above). Enhanced pleasure when listening to music seems to be common.	
In many cases, 5-MeO-MIPT in rather low doses up to 5 mgs is reported to be smooth, relaxing, friendly and sense enhancing. It is reported to produce emotionally lability. Some experience the coming up period as being somewhat cold and shivery. To prevent dehydration drink a lot during the experiment.	
Smoked, it can produce a rush including trippiness. Visual effects are more often reported when smoked than after oral ingestion. The acute rushing phase lasts about 30 min and then declines slowly producing a trippy feeling for the next few hours, with baseline reached in 6-7 hrs. So the total duration of smoked-5-MeO-MIPT is comparable to an oral dose experiment in higher doses.	
As with other entheogens, it is unsafe to drive or use dangerous equipment with 5-MeO-MIPT because it affects attention span, visual acuity, concentration, and coordination.
experienceReports :: null

[Images]
imageEntryList :: 5-MeO-MiPT	https://www.erowid.org/chemicals/show_image.php?i=5meo_mipt/5meo_mipt_vial__i2005e1388_disp.jpg	A vial containing 500 mg of 5-MeO-MiPT. [Japan]	Photo by AcQuio. &copy; 2006 Erowid.org
5-MeO-MiPT	https://www.erowid.org/chemicals/show_image.php?i=5meo_mipt/5meo_mipt__i2005e1593_disp.jpg	A small zip lock bag containing 100 mg of 5MEO-MIPT powder, next to a pen for size comparision. [Spain]	Photo by Kyle. &copy; 2006 Erowid.org

[Law]
legalTable :: U.S. FEDERAL LEGAL SUMMARY
5-MeO-MIPT
REGULATED	No
STATUS	Not Approved ForHuman Consumption
SCHEDULE	Possible Analog
federalLawText :: 5-MeO-MIPT is uncontrolled in the United States. This means it is generally considered legal to buy, possess, and distribute (sell, trade or give).	It is possible that it could be considered an analog (of 5-MeO-DIPT, in which case, sales for human consumption or possession with the intent to ingest could be prosecuted under the Federal Analogue Act though we are unaware of any existing federal cases. (Jul 7 2005)	
The DEA has stated in their March 2005 issue of Microgram, that "5-MeO- MiPT is controlled (Schedule I) as an analogue of 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT, also known as 'Foxy-Methoxy')."
stateLaw :: Florida	5-MeO-MIPT (listed as 5-Methoxy-N-methyl-N-isopropyltryptamine) is Schedule I in Florida. (see http://www.leg.state.fl.us/Statutes/index.cfm?App_mode=Display_Statute&URL=0800-0899/0893/Sections/0893.03.html). (thanks m) (last updated Oct 6, 2015)
Louisiana	2C-C, 2C-E, 2C-D, 2C-T-2, 2C-T 2C-T-4, 2C-H, 2C-N, 2C-P, 4-FA, 4-FMA, 6-APDB, 5-APDB, 5-APB6-APB, MDAI, 5-IAI, 4-HO-DIPT, 5-MeO-DMT, 5-MeO-MIPT, 5-MeO-DALT, DIPT, Methoxetamine, and the NBOMe compounds are Schedule I (as of June 2013). See http://www.legis.state.la.us/lss/lss.asp?doc=98877. (thanks ch) (last updated Mar 15, 2014)
Minnesota	Minnesota banned a series of drugs including 5-MeO-MIPT. The list includes 2C-C, 2C-E, 2C-D, 2C-T-4, 2C-I, 4-FA (fluoramphetamine), fluoromethamphetamine (4-FMA), 6-APDB, MDAI, 5-IAI, 4-HO-DIPT, DIPT, 5-MeO-DMT, 5-MeO-MIPT, 5-MeO-DALT, Methoxetamine (MXE), 25I-NBOMe, and others. See https://www.revisor.mn.gov/statutes/?id=152.02. (thanks s) (last updated Aug 29, 2015)
internationalLaw :: China	Controlled in China as a Category I psychotropic substance, illegal to sell, buy, import, export, and manufacture 4-methylmethcathinone as of September 2010. See China's SFDA announcement. (thanks n) (last updated Nov 25, 2015)
Finland	5-MeO-MIPT was banned in Finland in December 2014. A new government regulation was enacted in Finland that banned over 100 psychoactive chemicals. See Finland's Prohibited Psychoactive Substances: December 19, 2014. (last updated Dec 26, 2014)
Japan	5-MeO-MIPT is controlled as a "Designated Substance" (Shitei-Yakubutsu) by the Pharmaceutical Affairs Law, making it illegal to possess or sell (see Ref)

[Dose]
doseTable :: null
doseText :: Smoked/Vaporized 5-MeO-MIPT: We have received report that smoking/vaporizing requires larger quantities of material to achieve similar effects to oral. The tentative doses below are based on very limited data.
notes :: null

[Chemistry]
chemTable :: NAME :	5-MeO-MIPT
CHEMICAL NAME :	N-isopropyl-5-methoxy-N-methyl-tryptamine; N-[2-(5-methoxy-1 H-indol-3-y)ethyl]-N-methylpropan-2-amine
ALTERNATE NAME :	None
CHEMICAL FORMULA :	C15H22N2O
Melting Point :	between 100-150ï¿½ C
moleculeURL :: null

[ResearchChemical]
url :: https://www.erowid.org/psychoactives/research_chems/research_chems.shtml
summaryText :: Chemicals marked on Erowid by our Research Chemical Symbol should be considered experimental chemicals.	Although some people are willing to ingest these chemicals for their effects, it is not reasonable	to assume that these chemicals are in any way 'safe' to use recreationally. Although	all psychoactive use involves risk, many substances in this class of chemicals have undergone virtually no human or animal toxicity studies. Research chemicals are those for which there is little to no data on possible long term problems, addiction potential, allergic reactions, or acute overdoses.	
Publication of information by Erowid about human use of these chemicals is not intended to	endorse their non-laboratory use. It is important to remember that reactions to psychoactives vary	dramatically from person to person. Extrapolating anything from any single person's experience with a chemical is inappropriate and may result in dangerous and possibly fatal adverse reactions.	
Some reports of use may include extremely glowing "wow"-type experiences. Reports of this nature	should not be misunderstood to suggest that they are common or typical of those who ingest the	substance, or that the effects will be pleasant or desirable.	
Additionally, the reliability of many sources of these products can be questionable. Mislabeling,	misidentification, issues of purity, adulteration, and misrepresentation (substitution) are unfortunately a	common problem with research chemicals.	
Consider carefully before choosing to use these substances.
